June 2019; 9 (3) Correction
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist
First published June 10, 2019, DOI: https://doi.org/10.1212/CPJ.0000000000000676
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist
Neurol Clin Pract Jun 2019, 9 (3) 184; DOI: 10.1212/CPJ.0000000000000676
Citation Manager Formats
Make Comment
See Comments
See original article:

In the infographic for the article “Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist" by Fox et al.,1 first published online January 8, 2019, a red “X” should have appeared on the arrow pointing to “egress into bloodstream.” This was corrected online on February 11, 2019. The authors regret the error.
- © 2019 American Academy of Neurology
Reference
- 1.↵
- Fox EJ,
- Buckle GJ,
- Singer B,
- Singh V, and
- Boster A
The Nerve!: Rapid online correspondence
No comments have been published for this article.
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement